BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 17350650)

  • 1. Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.
    Johnson RJ; McCoy JG; Bingman CA; Phillips GN; Raines RT
    J Mol Biol; 2007 Apr; 368(2):434-49. PubMed ID: 17350650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific mutagenesis reveals differences in the structural bases for tight binding of RNase inhibitor to angiogenin and RNase A.
    Chen CZ; Shapiro R
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1761-6. PubMed ID: 9050852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor.
    Iyer S; Holloway DE; Kumar K; Shapiro R; Acharya KR
    J Mol Biol; 2005 Apr; 347(3):637-55. PubMed ID: 15755456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
    Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
    J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution.
    Papageorgiou AC; Shapiro R; Acharya KR
    EMBO J; 1997 Sep; 16(17):5162-77. PubMed ID: 9311977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A.
    Kobe B; Deisenhofer J
    J Mol Biol; 1996 Dec; 264(5):1028-43. PubMed ID: 9000628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot".
    Shapiro R; Ruiz-Gutierrez M; Chen CZ
    J Mol Biol; 2000 Sep; 302(2):497-519. PubMed ID: 10970748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraspecies regulation of ribonucleolytic activity.
    Johnson RJ; Lavis LD; Raines RT
    Biochemistry; 2007 Nov; 46(45):13131-40. PubMed ID: 17956129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
    Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
    J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandemization endows bovine pancreatic ribonuclease with cytotoxic activity.
    Leich F; Köditz J; Ulbrich-Hofman R; Arnold U
    J Mol Biol; 2006 May; 358(5):1305-13. PubMed ID: 16580680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of human pancreatic ribonuclease with human ribonuclease inhibitor. Generation of inhibitor-resistant cytotoxic variants.
    Gaur D; Swaminathan S; Batra JK
    J Biol Chem; 2001 Jul; 276(27):24978-84. PubMed ID: 11342552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional structure of human RNase 1 delta N7 at 1.9 A resolution.
    Pous J; Mallorquí-Fernández G; Peracaula R; Terzyan SS; Futami J; Tada H; Yamada H; Seno M; de Llorens R; Gomis-Rüth FX; Coll M
    Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):498-505. PubMed ID: 11264578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coulombic effects of remote subsites on the active site of ribonuclease A.
    Fisher BM; Schultz LW; Raines RT
    Biochemistry; 1998 Dec; 37(50):17386-401. PubMed ID: 9860854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence assay for the binding of ribonuclease A to the ribonuclease inhibitor protein.
    Abel RL; Haigis MC; Park C; Raines RT
    Anal Biochem; 2002 Jul; 306(1):100-7. PubMed ID: 12069420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribonuclease A variants with potent cytotoxic activity.
    Leland PA; Schultz LW; Kim BM; Raines RT
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10407-12. PubMed ID: 9724716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superadditive and subadditive effects of "hot spot" mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A.
    Chen CZ; Shapiro R
    Biochemistry; 1999 Jul; 38(29):9273-85. PubMed ID: 10413501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of human placental ribonuclease with placental ribonuclease inhibitor.
    Shapiro R; Vallee BL
    Biochemistry; 1991 Feb; 30(8):2246-55. PubMed ID: 1998683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of bovine seminal ribonuclease: monomer versus dimer.
    Lee JE; Raines RT
    Biochemistry; 2005 Dec; 44(48):15760-7. PubMed ID: 16313179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-oxidative effect of ribonuclease inhibitor by site-directed mutagenesis and expression in Pichia pastoris].
    Wu Y; Zhao BC; Wang JH; Zhao P; Wu YN; Cui XY
    Yi Chuan; 2005 Mar; 27(2):249-54. PubMed ID: 15843355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational stability is a determinant of ribonuclease A cytotoxicity.
    Klink TA; Raines RT
    J Biol Chem; 2000 Jun; 275(23):17463-7. PubMed ID: 10747991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.